Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|February 27, 2019
Distinguishing Between Cyclopropylfentanyl and Crotonylfentanyl by Methods Commonly Available in the Forensic LaboratoryMarianne Skov-Skov Bergh, Inger Lise Bogen, Ariane Wohlfarth, et al.
Addiction (Abingdon, England)|November 20, 2009
Urine tested positive for ethyl glucuronide after trace amounts of ethanolAnnette Thierauf, Claudia C Halter, Sumandeep Rana, et al.
Analytica Chimica Acta|October 26, 2016
Untargeted screening of unknown xenobiotics and potential toxins in plasma of poisoned patients using high-resolution mass spectrometry: Generation of xenobiotic fingerprint using background subtractionChang Chen, Ariane Wohlfarth, Hui Xu, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2018
Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male RatsJeremy Carlier, Ariane Wohlfarth, Bonita D Salmeron, et al.
Journal of Chromatography. A|May 23, 2016
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometryJeremy Carlier, Karl B Scheidweiler, Ariane Wohlfarth, et al.
The AAPS Journal|January 17, 2017
Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine SamplesSvante Vikingsson, Ariane Wohlfarth, Mikael Andersson, et al.
The AAPS Journal|February 28, 2015
Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAAriane Wohlfarth, Marisol S Castaneto, Mingshe Zhu, et al.
Drug Metabolism Reviews|April 9, 2015
Synthetic cannabinoids pharmacokinetics and detection methods in biological matricesMarisol S Castaneto, Ariane Wohlfarth, Nathalie A Desrosiers, et al.
Drug Testing and Analysis|May 16, 2014
High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomesAdarsh S Gandhi, Ariane Wohlfarth, Mingshe Zhu, et al.
Clinical Chemistry|September 10, 2013
First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometryAriane Wohlfarth, Shaokun Pang, Mingshe Zhu, et al.
Pageof 5